ES2138659T3 - Sistemas terapeuticos transdermales para la administracion de agonistas de la serotonina. - Google Patents

Sistemas terapeuticos transdermales para la administracion de agonistas de la serotonina.

Info

Publication number
ES2138659T3
ES2138659T3 ES94915109T ES94915109T ES2138659T3 ES 2138659 T3 ES2138659 T3 ES 2138659T3 ES 94915109 T ES94915109 T ES 94915109T ES 94915109 T ES94915109 T ES 94915109T ES 2138659 T3 ES2138659 T3 ES 2138659T3
Authority
ES
Spain
Prior art keywords
administration
transdermal therapeutic
therapeutic systems
serotonin agonists
serotonin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94915109T
Other languages
English (en)
Inventor
Harald List
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Application granted granted Critical
Publication of ES2138659T3 publication Critical patent/ES2138659T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA INVENCION SE REFIERE A SISTEMAS TERAPEUTICOS TRANSDERMALES PARA LA ADMINISTRACION SISTEMATICA DE SUSTANCIA ACTIVA, QUE SE CARACTERIZA DE TAL MODO, QUE AL MENOS UNA DE LAS SUSTANCIAS ACTIVAS ES UN AGONISTA DE SEROTONINA A PARTIR DEL GRUPO DE DERIVADOS INDOL, POR EJEMPLO SUMATRIPTAN.
ES94915109T 1993-05-06 1994-04-25 Sistemas terapeuticos transdermales para la administracion de agonistas de la serotonina. Expired - Lifetime ES2138659T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4314976A DE4314976C1 (de) 1993-05-06 1993-05-06 Transdermale therapeutische Systeme zur Verabreichung von Wirkstoffen, Verfahren zu ihrer Herstellung und ihre Verwendung

Publications (1)

Publication Number Publication Date
ES2138659T3 true ES2138659T3 (es) 2000-01-16

Family

ID=6487316

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94915109T Expired - Lifetime ES2138659T3 (es) 1993-05-06 1994-04-25 Sistemas terapeuticos transdermales para la administracion de agonistas de la serotonina.

Country Status (20)

Country Link
EP (1) EP0697869B1 (es)
JP (1) JPH08509749A (es)
KR (1) KR960702306A (es)
AT (1) ATE183392T1 (es)
AU (1) AU686159B2 (es)
CA (1) CA2160776A1 (es)
CZ (1) CZ289395A3 (es)
DE (2) DE4314976C1 (es)
DK (1) DK0697869T3 (es)
ES (1) ES2138659T3 (es)
FI (1) FI955260A7 (es)
GR (1) GR3031639T3 (es)
HU (1) HUT74865A (es)
IL (1) IL109509A (es)
NO (1) NO954414D0 (es)
NZ (1) NZ265949A (es)
PL (1) PL179353B1 (es)
SK (1) SK138095A3 (es)
WO (1) WO1994026270A1 (es)
ZA (1) ZA942872B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4467396A (en) 1994-12-12 1996-07-10 Omeros Medical Systems, Inc. Irrigation solution and method for inhibition of pain, inflammation and spasm
US8022095B2 (en) 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
EP1170006B8 (en) * 1999-12-14 2008-03-19 Teikoku Seiyaku Co., Ltd. Drug for alleviating migraine
US20030013753A1 (en) * 2001-06-05 2003-01-16 Ronald Aung-Din Transdermal migraine therapy
US8329734B2 (en) 2009-07-27 2012-12-11 Afgin Pharma Llc Topical therapy for migraine
ES2380827T3 (es) 2002-12-26 2012-05-18 Pozen, Inc. Formas de dosificación con múltiples capas que contienen naproxeno y triptanes
EP1644004A4 (en) 2003-06-20 2010-10-06 Ronald Aung-Din LOCAL THERAPY FOR THE TREATMENT OF MIGRAINS, MUSCLE CLARIFICATIONS, MUSCLE SPASMS, SPASTICITY AND RELATED CONDITIONS
EP1962837A4 (en) 2005-12-20 2011-12-14 Teikoku Pharma Usa Inc METHODS OF PERCUTANEOUS DELIVERY OF INDOLIC SEROTONIN RECEPTOR AGONIST AND PERCUTANEOUS COMPOSITIONS FOR USE THEREIN
WO2007120747A2 (en) 2006-04-13 2007-10-25 Nupathe Inc. Transdermal methods and systems for the delivery of anti-migraine compounds
CA2729346A1 (en) 2008-06-30 2010-01-14 Afgin Pharma, Llc Topical regional neuro-affective therapy
NZ599344A (en) 2009-09-25 2015-02-27 Reddy’S Lab Ltd Dr Formulations comprising triptan compounds
US11337962B2 (en) 2009-09-25 2022-05-24 Upsher-Smith Laboratories, Llc Formulations comprising triptan compounds
JP6216151B2 (ja) * 2013-04-19 2017-10-18 コスメディ製薬株式会社 親水性薬物のエマルジョンパッチ
BR112017018944A2 (en) 2015-03-02 2018-05-15 Afgin Pharma, Llc method of treating a disease state or condition in humans with a carbinoid drug, and method of treating a disease state or condition in a mammal other than a human with carbinoid drug (s)
US10383816B2 (en) 2015-03-02 2019-08-20 Afgin Pharma, Llc Topical regional neuro-affective therapy with cannabinoid combination products
US20180049994A1 (en) 2016-08-16 2018-02-22 Afgin Pharma, Llc Topical regional neuro-affective therapy with caryophyllene

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3742951A (en) * 1971-08-09 1973-07-03 Alza Corp Bandage for controlled release of vasodilators
US3996934A (en) * 1971-08-09 1976-12-14 Alza Corporation Medical bandage
US5288498A (en) * 1985-05-01 1994-02-22 University Of Utah Research Foundation Compositions of oral nondissolvable matrixes for transmucosal administration of medicaments
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
AU8072691A (en) * 1990-06-28 1992-01-23 Beecham Group Plc Pharmaceutical preparations
GB9103770D0 (en) * 1991-02-22 1991-04-10 Glaxo Group Ltd Chemical compounds
GB9104890D0 (en) * 1991-03-08 1991-04-24 Glaxo Group Ltd Compositions

Also Published As

Publication number Publication date
FI955260A0 (fi) 1995-11-02
KR960702306A (ko) 1996-04-27
PL179353B1 (en) 2000-08-31
GR3031639T3 (en) 2000-02-29
IL109509A0 (en) 1994-08-26
AU6648094A (en) 1994-12-12
EP0697869B1 (de) 1999-08-18
JPH08509749A (ja) 1996-10-15
SK138095A3 (en) 1996-06-05
NO954414L (no) 1995-11-03
AU686159B2 (en) 1998-02-05
WO1994026270A1 (de) 1994-11-24
HU9503167D0 (en) 1996-01-29
NZ265949A (en) 1997-10-24
CZ289395A3 (en) 1996-04-17
HUT74865A (en) 1997-02-28
NO954414D0 (no) 1995-11-03
IL109509A (en) 1999-12-22
CA2160776A1 (en) 1994-11-24
DK0697869T3 (da) 2000-03-20
EP0697869A1 (de) 1996-02-28
DE4314976C1 (de) 1994-10-06
DE59408643D1 (de) 1999-09-23
ZA942872B (en) 1995-07-06
FI955260L (fi) 1995-11-17
PL311591A1 (en) 1996-02-19
FI955260A7 (fi) 1995-11-17
ATE183392T1 (de) 1999-09-15

Similar Documents

Publication Publication Date Title
ES2159591T3 (es) Composicion de liberacion controlada.
SV2004001556A (es) Preparaciones acidas de insulina con establidad mejorada
ES2192234T3 (es) Composiciones farmaceuticas parenterales conteniendo sales de amonioalquilo de acidos 2-arilpropionicos.
CO5070580A1 (es) Formulacion farmaceutica para aerosoles con dos o mas sustancias activas
ES2161697T3 (es) Peptidos agonistas de amilina y usos de los mismos.
NO20071498L (no) Substituerte acylhydroksamsyrer samt fremgangsmate for a redusere TNFa-nivaet
AR035348A1 (es) Indoles sustituidos, composiciones farmaceuticas que los comprenden, y uso de dichos compuestos en la preparacion de medicamentos
AR033423A1 (es) Sales farmaceuticas constituidas de una sustancia activa farmaceutica y al menos un edulcorante, medicamentos que contienen estas sales y uso de estas sales para la preparacion de medicamentos
UY26242A1 (es) Nueva formulacion ley 17164
BR9713186A (pt) Inibidores de metaloprotease 1,3-diheterocìclicos
BR9713178A (pt) Inbidores espirocìclicos da metaloprotease.
MA56661B1 (fr) Formes cristallines de 7-chloro-2-(4-(3-méthoxyazétidine-1-yl))cyclohexyl) 2,4-diméthyl-n-((6-méthyl-4-(méthylthio)-2-oxo-1,2-dihydropyridine-3-yl) méthyl)benzo[d][1,3]dioxole-5-carboxamide
ES2067874T3 (es) Derivados de acetamida.
ES2083597T3 (es) Preparacion farmaceutica para el tratamiento del tiempo de coagulacion prolongado.
AR024998A1 (es) Nuevos retinoides para el tratamiento del enfisema
ES2052015T3 (es) Un metodo de preparacion de una composicion farmaceutica.
ECSP930933A (es) Composicion farmaceutica y procedimiento para prepararla
NO954414L (no) Transdermale terapeutiske systemer for administrering av serotonin-agonister
UY26371A1 (es) Imidazo-3-il-aminas biciclicas, procedimiento para su preparacion y medicamentos que las contienen
AR021750A1 (es) Aparato para el tratamiento topico localizado de una enfermedad
PT1194415E (pt) Novos derivados da piperazinil-alquil-tiopirimidina composicoes farmaceuticas que os contem e um processo de preparacao da substancia activa
ES2156220T3 (es) Preparacion transdermica que contiene un metabolito de loratidina con accion antihistaminica.
AR016382A1 (es) Uso de un derivado del acido bencil-indazol metoxialcanoico.
ES2123499T3 (es) Metodos y composiciones para tratamiento de infecciones virales.
AR023700A1 (es) Un procedimiento para preparar una composicion farmaceutica que comprende un sensibilizador de insulina

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 697869

Country of ref document: ES